SCHEMBL7849540

SCHEMBL7849540

CCCCc1cn(Cc2ccc(-c3ccccc3C(=O)O)cc2)c2c(c1=O)CCCC2

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 9/20 0.56
AGTR2 P50052 5/20 0.56
LTB4R2 Q9NPC1 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8502142 0.90 ACHE (0.54) AGTR1AGTR2LTB4R2
SCHEMBL7847610 0.89 AGTR1 (0.50) AGTR1AGTR2
SCHEMBL7850545 0.88 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL8325773 0.86 AGTR1 (0.40) AGTR1AGTR2LTB4R2
SCHEMBL8410401 0.84 AGTR1 (0.46) AGTR1AGTR2LTB4R2
SCHEMBL8325939 0.82 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL8525724 0.80 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL8327991 0.79 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL8413083 0.79 ACHE (0.47) AGTR1AGTR2LTB4R2
SCHEMBL8678184 0.79 AGTR1 (0.41) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0498723-B1 Nitrogen containing bicycle compounds, method for their preparation, their use as pharmaceutical and compositions containing them AVENTIS PHARMA SA (FR) 2001-09-19 EP disclosed
US-6004979-A ANGIOTENSIN II INHIBITORS; 4-((CARBOXY)ARYLOXY)-QUINOLINE DERIVATIVES HOECHST MARION ROUSSEL (FR) 1999-12-21 US disclosed
US-5985894-A USEFUL IN THE TREATMENT OF CARDIOVASCULAR ILLNESSES HOECHST MARION ROUSSEL (FR) 1999-11-16 US disclosed
US-5817674-A ANTIOTENSIN II RECEPTOR ANTAGONISTS ROUSSEL UCLAF (FR) 1998-10-06 US disclosed
EP-0498723-A1 Nitrogen containing bicycle compounds, method for their preparation, their use as pharmaceutical and compositions containing them ROUSSEL UCLAF (FR) 1992-08-12 EP disclosed